The following  presentation topic will be presented at the Hematologic Malignancy Grand Rounds Conference on Friday, December 13, 2013  from 9:15 a.m. - 10:15 a.m. in M224 Markee Classroom, Second Floor, Green Zone, Duke South Clinic's Davison Building.

" Treatment of Older Patients with High Risk Myelodysplastic Syndrome:  

A New Clinical Trial Option"

 

by  Mitchell Horwitz, MD

 

 

Disclosure:  Mitchell Horwitz, MD - Consultant for Gamida cell, PI for Sanofi-Aventis, and Advisory Board Member for Spectrum.

Session date: 
Friday, December 13, 2013 - 9:15am to 10:15am
Location: 
Davison Building
Duke South Clinics Green Zone
2nd Floor, M224 Markee Classroom
Durham, NC 27710
United States

Please login or register to take this course.